The Department of Defense (DoD) is offering this grant to support new or existing partnerships between two or three independent investigators focused on innovative questions or problems in prostate cancer. This grant is for the purpose of fostering synergistic idea development with potential for significant impact, even for high-risk proposals. A preproposal is mandatory, and full applications are by invitation only. While preliminary data are encouraged, they are not a requirement. Key evaluation criteria include synergy, innovation, and the potential impact of the research. It is important to note that this funding opportunity does not support clinical trials.
Opportunity ID: 156613
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-12-PCRP-SIDA |
| Funding Opportunity Title: | DoD Prostate Cancer Synergistic Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 20, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 09, 2012 |
| Current Closing Date for Applications: | Aug 09, 2012 |
| Archive Date: | Sep 08, 2012 |
| Estimated Total Program Funding: | $6,000,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | Preproposal is required; application submission is by invitation only. Supports new or existing partnerships between two or three independent investigators to address a central innovative question or problem in prostate cancer that may include high risk, provided there is a potential for significant impact. Preliminary data are encouraged but not required. Synergy, Innovation, and Impact are the most important review criteria. Does not support clinical trials. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk: 301-682-5507
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 156613 Full Announcement-1 -> fy12 cdmrp gai final 12mar2012.pdf
Folder 156613 Full Announcement-1 -> pcrp_fy12_sida_pa_gg.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk: 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00108951 | Mar 20, 2012 | Aug 09, 2012 | View |
Package 1
Mandatory forms
156613 RR_SF424_1_2-1.2.pdf
156613 PerformanceSite_1_4-1.4.pdf
156613 RR_Budget-1.1.pdf
Optional forms
156613 RR_SubawardBudget30-1.2.pdf
156613 RR_KeyPersonExpanded_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
